Cargando…

Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzianowska-Kuźnicka, Monika, Owczarz, Magdalena, Wieczorowska-Tobis, Katarzyna, Nadrowski, Pawel, Chudek, Jerzy, Slusarczyk, Przemyslaw, Skalska, Anna, Jonas, Marta, Franek, Edward, Mossakowska, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891873/
https://www.ncbi.nlm.nih.gov/pubmed/27274758
http://dx.doi.org/10.1186/s12979-016-0076-x
_version_ 1782435339024990208
author Puzianowska-Kuźnicka, Monika
Owczarz, Magdalena
Wieczorowska-Tobis, Katarzyna
Nadrowski, Pawel
Chudek, Jerzy
Slusarczyk, Przemyslaw
Skalska, Anna
Jonas, Marta
Franek, Edward
Mossakowska, Malgorzata
author_facet Puzianowska-Kuźnicka, Monika
Owczarz, Magdalena
Wieczorowska-Tobis, Katarzyna
Nadrowski, Pawel
Chudek, Jerzy
Slusarczyk, Przemyslaw
Skalska, Anna
Jonas, Marta
Franek, Edward
Mossakowska, Malgorzata
author_sort Puzianowska-Kuźnicka, Monika
collection PubMed
description BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. RESULTS: IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n = 3496 individuals, p < 0.001 and CRP: n = 3632, p = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n = 1258, p < 0.001 and CRP: n = 1312, p < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n = 2238, p < 0.001 and CRP: n = 2320, p = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p < 0.001). CONCLUSIONS: Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals.
format Online
Article
Text
id pubmed-4891873
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48918732016-06-04 Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study Puzianowska-Kuźnicka, Monika Owczarz, Magdalena Wieczorowska-Tobis, Katarzyna Nadrowski, Pawel Chudek, Jerzy Slusarczyk, Przemyslaw Skalska, Anna Jonas, Marta Franek, Edward Mossakowska, Malgorzata Immun Ageing Research BACKGROUND: In the elderly, chronic low-grade inflammation (inflammaging) is a risk factor for the development of aging-related diseases and frailty. Using data from several thousand Eastern Europeans aged 65 years and older, we investigated whether the serum levels of two proinflammatory factors, interleukin-6 (IL-6) and C-reactive protein (CRP), were associated with physical and cognitive performance, and could predict mortality in successfully aging elderly. RESULTS: IL-6 and CRP levels systematically increased in an age-dependent manner in the entire study group (IL-6: n = 3496 individuals, p < 0.001 and CRP: n = 3632, p = 0.003), and in the subgroup of successfully aging individuals who had never been diagnosed with cardiovascular disease, myocardial infarction, stroke, type 2 diabetes, or cancer, and had a Mini Mental State Examination (MMSE) score ≥24 and a Katz Activities of Daily Living (ADL) score ≥5 (IL-6: n = 1258, p < 0.001 and CRP: n = 1312, p < 0.001). In the subgroup of individuals suffering from aging-related diseases/disability, only IL-6 increased with age (IL-6: n = 2238, p < 0.001 and CRP: n = 2320, p = 0.249). IL-6 and CRP levels were lower in successfully aging individuals than in the remaining study participants (both p < 0.001). Higher IL-6 and CRP levels were associated with poorer physical performance (lower ADL score) and poorer cognitive performance (lower MMSE score) (both p < 0.001). This association remained significant after adjusting for age, gender, BMI, lipids, estimated glomerular filtration rate, and smoking status. Longer survival was associated with lower concentrations of IL-6 and CRP not only in individuals with aging-related diseases/disability (HR = 1.063 per each pg/mL, 95 % CI: 1.052-1.074, p < 0.001 and HR = 1.020 per each mg/L, 95 % CI: 1.015-1.025, p < 0.001, respectively) but also in the successfully aging subgroup (HR = 1.163 per each pg/mL, 95 % CI: 1.128-1.199, p < 0.001 and HR = 1.074 per each mg/L, 95 % CI: 1.047-1.100, p < 0.001, respectively). These associations remained significant after adjusting for age, gender, BMI, lipids and smoking status. The Kaplan-Meier survival curves showed similar results (all p < 0.001). CONCLUSIONS: Both IL-6 and CRP levels were good predictors of physical and cognitive performance and the risk of mortality in both the entire elderly population and in successfully aging individuals. BioMed Central 2016-06-03 /pmc/articles/PMC4891873/ /pubmed/27274758 http://dx.doi.org/10.1186/s12979-016-0076-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Puzianowska-Kuźnicka, Monika
Owczarz, Magdalena
Wieczorowska-Tobis, Katarzyna
Nadrowski, Pawel
Chudek, Jerzy
Slusarczyk, Przemyslaw
Skalska, Anna
Jonas, Marta
Franek, Edward
Mossakowska, Malgorzata
Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title_full Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title_fullStr Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title_full_unstemmed Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title_short Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study
title_sort interleukin-6 and c-reactive protein, successful aging, and mortality: the polsenior study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891873/
https://www.ncbi.nlm.nih.gov/pubmed/27274758
http://dx.doi.org/10.1186/s12979-016-0076-x
work_keys_str_mv AT puzianowskakuznickamonika interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT owczarzmagdalena interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT wieczorowskatobiskatarzyna interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT nadrowskipawel interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT chudekjerzy interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT slusarczykprzemyslaw interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT skalskaanna interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT jonasmarta interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT franekedward interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy
AT mossakowskamalgorzata interleukin6andcreactiveproteinsuccessfulagingandmortalitythepolseniorstudy